Furthermore, IGF2BP1 directly interacted with tRF‐16, and later cellular tests indicated that tRF‐16 may impede lung cancer cell growth via modulating IGF2BP1 to suppress fatty acid metabolism in lung cancer cells. This evidence concerns the gene IGF2BP1 and lung carcinoma.